The glucagon-like peptide 1 analog liraglutide reduces TNF-α-induced oxidative stress and inflammation in endothelial cells. [electronic resource]
- Atherosclerosis Apr 2012
- 375-82 p. digital
Publication Type: Journal Article
1879-1484
10.1016/j.atherosclerosis.2011.12.039 doi
Anti-Inflammatory Agents--pharmacology Antioxidants--pharmacology Apoptosis--drug effects C-Reactive Protein--metabolism Catalase--metabolism Cells, Cultured Dose-Response Relationship, Drug Glucagon-Like Peptide 1--analogs & derivatives Glutathione Peroxidase--metabolism Human Umbilical Vein Endothelial Cells--drug effects Humans I-kappa B Kinase--metabolism I-kappa B Proteins--metabolism Inflammation Mediators--metabolism Liraglutide Membrane Glycoproteins--metabolism NADPH Oxidase 2 NADPH Oxidases--metabolism NF-kappa B--genetics Oxidative Stress--drug effects Phosphorylation Protein Kinase C-alpha--metabolism Protein Transport Reactive Oxygen Species--metabolism Recombinant Proteins--metabolism Serum Amyloid P-Component--metabolism Signal Transduction--drug effects Superoxide Dismutase--metabolism Time Factors Transfection Tumor Necrosis Factor-alpha--metabolism